303 related articles for article (PubMed ID: 15521788)
1. Combination therapy in Alzheimer's disease: a review of current evidence.
Schmitt B; Bernhardt T; Moeller HJ; Heuser I; Frölich L
CNS Drugs; 2004; 18(13):827-44. PubMed ID: 15521788
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
Cummings JL
Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
5. Current pharmacotherapies for Alzheimer's disease.
Knopman DS
Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
[TBL] [Abstract][Full Text] [Related]
6. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
[TBL] [Abstract][Full Text] [Related]
7. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
8. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
9. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
Xiong G; Doraiswamy PM
Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy for early Alzheimer's disease: what are we waiting for?
Doraiswamy PM; Steffens DC
J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922
[TBL] [Abstract][Full Text] [Related]
11. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
12. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.
Farlow MR; Miller ML; Pejovic V
Dement Geriatr Cogn Disord; 2008; 25(5):408-22. PubMed ID: 18391487
[TBL] [Abstract][Full Text] [Related]
13. Current pharmacotherapy for Alzheimer's disease.
Lleó A; Greenberg SM; Growdon JH
Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
15. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
Gauthier S; Molinuevo JL
Alzheimers Dement; 2013 May; 9(3):326-31. PubMed ID: 23110864
[TBL] [Abstract][Full Text] [Related]
16. [Is there a treatment for Alzheimer's disease?].
Joray S; Ghika J; von Gunten A; Büla C; Gold G; Assal F
Rev Med Suisse; 2005 May; 1(18):1201-2, 1205-6, 1208. PubMed ID: 15977708
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing.
Blaszczyk AT; Mang BH; Garza H; Mathys M
Consult Pharm; 2018 May; 33(5):273-282. PubMed ID: 29789049
[TBL] [Abstract][Full Text] [Related]
18. Current treatment for Alzheimer disease and future prospects.
Tariot PN; Federoff HJ
Alzheimer Dis Assoc Disord; 2003; 17 Suppl 4():S105-13. PubMed ID: 14512816
[TBL] [Abstract][Full Text] [Related]
19. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options in Alzheimer's disease.
Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
